The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.

Scientifically groundless regulations could undercut the potential of gene-edited crops, much as they have with GMOs.

Mauro Ferrari says the organization’s response to the COVID-19 pandemic is inadequate, but ERC members claim his proposals didn’t align with the mission of the council.

The plan to revitalize the European innovation landscape is entering a transition.

Higher ed professionals from EU and non-EU countries are departing for jobs elsewhere, perhaps reflecting uncertainty over funding availability.

Prime Minister Boris Johnson says the immigration program will help the nation remain a science superpower post-Brexit.

Public health care will take a hit however Britain leaves the European Union, but a no-deal exit will cause the most harm, a new analysis shows.

Nearly three dozen Nobel laureates and Fields Medal winners sign a letter to the UK Prime Minister and the President of the European Commission.

As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.

The European Court of Justice has decided that organisms made with precision techniques such as CRISPR will be subject to the same rules as transgenic plants or animals.

The plan would also allow non-EU countries to pay to participate in EU research programs, albeit without wielding “decisional power.”

The increase is associated with travel to Europe, where large outbreaks are occurring.

The budget is smaller than what some researchers hoped for, and too high for at least one EU member state.

The pesticides, which studies show are harmful to bees, will be prohibited in open fields by the end of 2018.

Despite some difficult negotiations, academic institutions in the Netherlands have been securing subscriptions that combine publishing and reading into one fee.

Alzheimer’s researcher John Hardy calls the departure “an unmitigated disaster” for science and healthcare in Britain.

Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.

A coin toss decides the agency’s post-Brexit home once it departs from London.

Some researchers have already been negatively affected by the U.K.’s decision to leave the European Union, though opinions on the eventual outcome remain mixed.